A molecular target of vascular calcification in chronic kidney disease
Vascular calcification (VC) causes cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD), particularly those with end-stage kidney disease (ESKD) on maintenance dialysis treatment. Although many mechanisms have been proposed, their detailed effects remain incompletely...
Main Author: | Mohamed G. Atta |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-01-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI156257 |
Similar Items
-
Targeting a Silent Disease: Vascular Calcification in Chronic Kidney Disease
by: Catarina Marreiros, et al.
Published: (2022-12-01) -
Food to Prevent Vascular Calcification in Chronic Kidney Disease
by: Diana Moldovan, et al.
Published: (2024-02-01) -
Redox Metabolism and Vascular Calcification in Chronic Kidney Disease
by: Natalia Carrillo-López, et al.
Published: (2023-09-01) -
Similarities and Differences of Vascular Calcification in Diabetes and Chronic Kidney Disease
by: Wang X, et al.
Published: (2024-01-01) -
Magnesium and Vascular Calcification in Chronic Kidney Disease: Current Insights
by: Shari J. Zaslow, et al.
Published: (2024-01-01)